127 related articles for article (PubMed ID: 31481233)
1. Crystal structure of dihydropyrimidinase in complex with anticancer drug 5-fluorouracil.
Huang YH; Ning ZJ; Huang CY
Biochem Biophys Res Commun; 2019 Oct; 519(1):160-165. PubMed ID: 31481233
[TBL] [Abstract][Full Text] [Related]
2. Molecular Insights into How the Dimetal Center in Dihydropyrimidinase Can Bind the Thymine Antagonist 5-Aminouracil: A Different Binding Mode from the Anticancer Drug 5-Fluorouracil.
Lin ES; Luo RH; Yang YC; Huang CY
Bioinorg Chem Appl; 2022; 2022():1817745. PubMed ID: 35198016
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of monometallic dihydropyrimidinase and the human dihydroorotase domain K1556A mutant reveal no lysine carbamylation within the active site.
Cheng JH; Huang YH; Lin JJ; Huang CY
Biochem Biophys Res Commun; 2018 Oct; 505(2):439-444. PubMed ID: 30268498
[TBL] [Abstract][Full Text] [Related]
4. The complexed crystal structure of dihydropyrimidinase reveals a potential interactive link with the neurotransmitter γ-aminobutyric acid (GABA).
Huang YH; Huang CY
Biochem Biophys Res Commun; 2024 Jan; 692():149351. PubMed ID: 38056157
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the interaction modes of dihydroorotase with the anticancer drugs 5-fluorouracil and 5-aminouracil.
Guan HH; Huang YH; Lin ES; Chen CJ; Huang CY
Biochem Biophys Res Commun; 2021 Apr; 551():33-37. PubMed ID: 33714757
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the single-stranded DNA-binding protein SsbB in complex with the anticancer drug 5-fluorouracil: Extension of the 5-fluorouracil interactome to include the oligonucleotide/oligosaccharide-binding fold protein.
Lin ES; Huang CY
Biochem Biophys Res Commun; 2021 Jan; 534():41-46. PubMed ID: 33310186
[TBL] [Abstract][Full Text] [Related]
7. Functional Characterization of 12 Dihydropyrimidinase Allelic Variants in Japanese Individuals for the Prediction of 5-Fluorouracil Treatment-Related Toxicity.
Hishinuma E; Narita Y; Rico EMG; Ueda A; Obuchi K; Tanaka Y; Saito S; Tadaka S; Kinoshita K; Maekawa M; Mano N; Nakayoshi T; Oda A; Hirasawa N; Hiratsuka M
Drug Metab Dispos; 2023 Feb; 51(2):165-173. PubMed ID: 36414408
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of dihydropyrimidinase from Pseudomonas aeruginosa PAO1: Insights into the molecular basis of formation of a dimer.
Tzeng CT; Huang YH; Huang CY
Biochem Biophys Res Commun; 2016 Sep; 478(3):1449-55. PubMed ID: 27576201
[TBL] [Abstract][Full Text] [Related]
9. Complexed Crystal Structure of the Dihydroorotase Domain of Human CAD Protein with the Anticancer Drug 5-Fluorouracil.
Lin ES; Huang YH; Yang PC; Peng WF; Huang CY
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671534
[TBL] [Abstract][Full Text] [Related]
10. Structure, catalytic mechanism, posttranslational lysine carbamylation, and inhibition of dihydropyrimidinases.
Huang CY
Adv Protein Chem Struct Biol; 2020; 122():63-96. PubMed ID: 32951816
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of 21 allelic variants of dihydropyrimidinase.
Hishinuma E; Akai F; Narita Y; Maekawa M; Yamaguchi H; Mano N; Oda A; Hirasawa N; Hiratsuka M
Biochem Pharmacol; 2017 Nov; 143():118-128. PubMed ID: 28642038
[TBL] [Abstract][Full Text] [Related]
12. Binding Pattern and Structural Interactome of the Anticancer Drug 5-Fluorouracil: A Critical Review.
Lin ES; Huang CY
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542377
[TBL] [Abstract][Full Text] [Related]
13. The crystal structures of dihydropyrimidinases reaffirm the close relationship between cyclic amidohydrolases and explain their substrate specificity.
Lohkamp B; Andersen B; Piškur J; Dobritzsch D
J Biol Chem; 2006 May; 281(19):13762-13776. PubMed ID: 16517602
[TBL] [Abstract][Full Text] [Related]
14. Purification, characterization and inhibition of dihydropyrimidinase from rat liver.
Kikugawa M; Kaneko M; Fujimoto-Sakata S; Maeda M; Kawasaki K; Takagi T; Tamaki N
Eur J Biochem; 1994 Jan; 219(1-2):393-9. PubMed ID: 8307005
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of DNA Replication Protein SsbA Complexed with the Anticancer Drug 5-Fluorouracil.
Su HH; Huang YH; Lien Y; Yang PC; Huang CY
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834349
[TBL] [Abstract][Full Text] [Related]
16. Structural Analysis of
Guan HH; Huang YH; Lin ES; Chen CJ; Huang CY
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885830
[TBL] [Abstract][Full Text] [Related]
17. PYD2 encodes 5,6-dihydropyrimidine amidohydrolase, which participates in a novel fungal catabolic pathway.
Gojkovic Z; Jahnke K; Schnackerz KD; Piskur J
J Mol Biol; 2000 Jan; 295(4):1073-87. PubMed ID: 10656811
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure and pH-dependent allosteric regulation of human β-ureidopropionase, an enzyme involved in anticancer drug metabolism.
Maurer D; Lohkamp B; Krumpel M; Widersten M; Dobritzsch D
Biochem J; 2018 Jul; 475(14):2395-2416. PubMed ID: 29976570
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of Cyclic Amidohydrolases.
Huang CY
PLoS One; 2015; 10(5):e0127634. PubMed ID: 25993634
[TBL] [Abstract][Full Text] [Related]
20. Structure and mapping of spontaneous mutational sites of PyrR from Mycobacterium tuberculosis.
Ghode P; Ramachandran S; Bifani P; Sivaraman J
Biochem Biophys Res Commun; 2016 Mar; 471(4):409-15. PubMed ID: 26902118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
